Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
sympathomimetic agent
A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
dopamine uptake inhibitor
A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake.
adrenergic uptake inhibitor
Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.
|
|
sympathomimetic agent
A drug that mimics the effects of stimulating postganglionic adrenergic sympathetic nerves. Included in this class are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.
dopamine uptake inhibitor
A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake.
appetite depressant
Agent that is used to decrease appetite.
adrenergic uptake inhibitor
Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin.
central nervous system stimulant
Any drug that enhances the activity of the central nervous system.
(via amphetamines )
|
|
(2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine
|
(+)-benzphetamine
|
ChEBI
|
(+)-N,α-dimethyl-N-(phenylmethyl)-benzeneethanamine
|
ChEBI
|
(+)-N-benzyl-N,α-dimethylphenethylamine
|
ChEBI
|
(αS)-N,α-dimethylphenethylamine
|
ChEBI
|
(S)-(+)-benzphetamine
|
ChEBI
|
(S)-(+)-N-benzyl-N,α-dimethylphenethylamine
|
ChEBI
|
(S)-benzphetamine
|
ChEBI
|
benzaphetamine
|
NIST Chemistry WebBook
|
Benzfetamine
|
KEGG COMPOUND
|
Benzphetamine
|
KEGG COMPOUND
|
benzylamphetamine
|
DrugBank
|
d-N-methyl-N-benzyl-β-phenylisopropylamine
|
ChEBI
|
N-methyl-1-phenyl-N-(phenylmethyl)propan-2-amine
|
DrugBank
|
156-08-1
|
CAS Registry Number
|
NIST Chemistry WebBook
|
156-08-1
|
CAS Registry Number
|
ChemIDplus
|
3203999
|
Beilstein Registry Number
|
Beilstein
|